Cover ImageSALE
市場調查報告書

血液凝固檢驗的全球市場:2017∼2021年

Global Coagulation Testing Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 317277
出版日期 內容資訊 英文 81 Pages
訂單完成後即時交付
價格
Back to Top
血液凝固檢驗的全球市場:2017∼2021年 Global Coagulation Testing Market 2017-2021
出版日期: 2017年01月27日 內容資訊: 英文 81 Pages
簡介

血液凝固檢驗,有助於測量血液的凝固能力。所謂凝固,是血液由液體凝轉換成膠狀的流程。全球血液凝固檢驗市場,預計從2017年到2021年以6.43%的年度成長率發展。

本報告提供全球血液凝固檢驗市場相關調查分析,市場規模,各應用、技術、產品、終端用戶、地區的詳細的市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 調查範圍

  • 市場概要
  • 主要的產品

第3章 調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 市場區隔:各應用

  • 市場概要
  • 凝血酵素原時間(PT)
  • 活化部分凝血活酵素時間(APTT)
  • 凝血試驗(TT)
  • 活性化凝固時間(ACT)

第7章 市場區隔:各技術

  • 電化學
  • 光學

第8章 市場區隔:各產品

  • 市場概要
  • 消耗品
  • 器具、設備
  • 市場規模與預測

第9章 市場區隔:各終端用戶

  • 市場概要
  • 醫院、個人診療所
  • 居家照護

第10章 地區區分

  • 南北美洲的血液凝固檢驗市場
  • 歐洲、中東、非洲地區的血液凝固檢驗市場
  • 亞太地區的血液凝固檢驗市場

第11章 市場推動因素

  • 血液、凝固系疾病的增加伴隨的血液凝固檢驗設備的需求增加
  • 發展國的就地檢驗(POCT)的滲透率的上升
  • 由於感應技術的發展,簡便設備的登場

第12章 推動因素的影響

第13章 市場課題

  • 高額的全自動血液凝固設備
  • 電子病歷的連接性低
  • 由於法規上的課題,而阻礙設備的穩定供給的現狀

第14章 推動因素與課題的影響

第15章 市場趨勢

  • 線上行銷服務的擴大
  • 拋棄式血液凝固檢驗產品日益熱門
  • 在手術前後進行血液凝固檢驗的醫生增加

第16章 供應商情勢

  • 競爭環境
  • 競爭環境分析

第17章 主要供應商分析

  • Roche Diagnostics
  • Alere
  • Abbott Laboratories
  • Siemens Healthcare
  • 其他供應商

第18章 附錄

第19章 關於Technavio

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR11734

About Coagulation Testing

Coagulation testing helps measure the ability of blood to form a clot. Clotting occurs when blood converts from liquid to gel form. Coagulation tests are performed to analyze clotting disorders, such as hemorrhage and thrombosis. Many types of coagulation tests exist, including complete blood count, factor V assay, fibrinogen level, prothrombin time, platelet count, thrombin time, and bleeding time. Coagulation testing analyzers play a major role in improving the quality of life of patients.

Technavio's analysts forecast the global coagulation testing market to grow at a CAGR of 6.43% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global coagulation testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the various segments which includes products, application, and technology.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Coagulation Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Roche Diagnostics
  • Alere
  • Abbott Laboratories
  • Siemens Healthcare

Other Prominent Vendors

  • Accriva Diagnostics
  • CoaguSense
  • Diagon
  • Helena Laboratories
  • HemoSonics
  • iLine Microsystems
  • Medtronic
  • Micropoint Bioscience
  • Sysmex

Market driver

  • Increased penetration of POCT devices in developed countries
  • For a full, detailed list, view our report

Market challenge

  • High cost of fully-automated hemostasis equipment
  • For a full, detailed list, view our report

Market trend

  • Increase in online marketing services
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our procurement specialist's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by application

  • Market overview
  • PT
  • aPTT
  • TT
  • ACT

PART 07: Market segmentation by technology

  • Electrochemical
  • Optical

PART 08: Market segmentation by product

  • Market overview
  • Consumables
  • Market size and forecast
  • Instruments

PART 09: Market segmentation by end-user

  • Market overview
  • Hospitals and private clinics
  • Home care

PART 10: Geographical segmentation

  • Global coagulation testing market in the Americas
  • Global coagulation testing market in EMEA
  • Global coagulation testing market in APAC

PART 11: Market drivers

  • Increasing prevalence of coagulation disorders driving the demand for coagulation testing devices
  • Increased penetration of POCT devices in developed countries
  • Technological advancements in sensors technology leads to faster and easy-to-use devices

PART 12: Impact of drivers

PART 13: Market challenges

  • High cost of fully-automated hemostasis equipment
  • Low data management and EHR connectivity
  • Regulatory challenges restrict the availability of the devices in the market

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Increase in online marketing services
  • Growing popularity of disposable coagulation testing products
  • Increasing physician preference for coagulation tests in pre-and post-surgical proceedings

PART 16: Vendor landscape

  • Competitive scenario
  • Competitive landscape analysis

PART 17: Key vendor analysis

  • Roche Diagnostics
  • Alere
  • Abbott Laboratories
  • Siemens Healthcare
  • Other prominent vendors

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global coagulation testing market 2016-2021 ($ billions)
  • Exhibit 03: Global coagulation testing market: Opportunity analysis
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global coagulation testing market by application 2016 and 2021 (%)
  • Exhibit 06: Global POC coagulation market by application 2016 and 2021 (%)
  • Exhibit 07: Global coagulation testing market by technology
  • Exhibit 08: Global coagulation electrochemical sensors testing market ($ billions)
  • Exhibit 09: Global coagulation optical biosensors testing market ($ billions)
  • Exhibit 10: Global coagulation testing consumables market ($ billions)
  • Exhibit 11: Global coagulation testing consumables market strategy analysis
  • Exhibit 12: Global coagulation instruments market 2015-2020 ($ billions)
  • Exhibit 13: Global coagulation testing instrument market strategy analysis
  • Exhibit 14: Global coagulation testing market 2016-2021 (%)
  • Exhibit 15: Global coagulation market analysis by hospitals and private clinics
  • Exhibit 01: Global coagulation market analysis by home care
  • Exhibit 02: Global coagulation testing market share by geography 2016-2021 (%)
  • Exhibit 03: Global coagulation testing market in Americas 2016-2021 ($ billion)
  • Exhibit 04: Global coagulation testing market in EMEA 2016-2021 ($ billions)
  • Exhibit 05: Global coagulation testing market in APAC 2016-2021 ($ billions)
  • Exhibit 06: Coagulation disorder market matrix
  • Exhibit 07: Impact of drivers
  • Exhibit 08: Cost analysis of coagulation devices
  • Exhibit 09: Impact of drivers and challenges
  • Exhibit 10: Competitive structure analysis of global coagulation testing market 2016
  • Exhibit 11: Competitive landscape analysis of global coagulation testing market (2016)
  • Exhibit 12: Roche Diagnostics: Key highlights
  • Exhibit 13: Roche Diagnostics: Strength assessment
  • Exhibit 14: Roche Diagnostics: Strategy assessment
  • Exhibit 15: Roche diagnostics: Opportunity assessment
  • Exhibit 16: Alere: Key highlights
  • Exhibit 17: Alere: Strength assessment
  • Exhibit 18: Alere: Strategy assessment
  • Exhibit 19: Alere: Opportunity assessment
  • Exhibit 20: Abbott Laboratories: Key highlights
  • Exhibit 21: Abbott Laboratories: Strength assessment
  • Exhibit 22: Abbott Laboratories: Strategy assessment
  • Exhibit 23: Abbott Laboratories: Opportunity assessment
  • Exhibit 24: Siemens Healthcare: Key highlights
  • Exhibit 25: Siemens Healthcare: Strength assessment
  • Exhibit 26: Siemens Healthcare: Strategy assessment
  • Exhibit 27: Siemens Healthcare: Opportunity assessment
  • Exhibit 28: Other prominent vendors
Back to Top